Comparative Analysis of Technical Efficiency in European Agriculture

Technical efficiency has long been analysed as a measure of farm performance, however most studies are restricted to a single country case. This paper presents a comparative analysis of field crop and dairy farm performance across eight EU countries, including two New Member States (NMS), focusing on long run stability and mobility patterns. The main research question is how relative performance of farms fluctuates over time, i.e. whether poorly performing farms remain always inefficient whilst some farms are always very efficient. Results show that on average 60% of farms maintain their efficiency ranking in two consecutive years, whilst 20% improve and 20% worsen their positions, for all countries. Due to the unstable economic conditions, farms in NMS are more mobile than those in EU15.Farm technical efficiency, SFA, FADN, stability analysis, Farm Management, P52, Q12,

FLINT – Farm-level Indicators for New Topics in policy evaluation: an introduction

Societal expectations about agricultural production are changing. There are increased demands on issues such as food safety, animal welfare and the impact of agriculture on the environment (land, water and air). These changes have been refl ected in the European Union’s (EU) Common Agricultural Policy (CAP), but information on these issues is lacking and this complicates the required evaluation of policies. The EU Framework 7 project FLINT tries to close this gap by analysing the feasibility of collecting data on these new topics. FLINT has established a data infrastructure with up-to-date farm-level indicators for themonitoring and evaluation of the CAP. The project created a pilot network of more than 1,000 farms to collect a set of sustainability indicators at farm level. The pilot represents farm diversity at EU level, including the different administrative environments in the Member States. This paper sets out the context and the main contributions of the project

Estimating bioturbation from replicated small-sample radiocarbon ages.

Marine sedimentary records are a key archive when reconstructing past climate; however, mixing at the seabed (bioturbation) can strongly influence climate records, especially when sedimentation rates are low. By commingling the climate signal from different time periods, bioturbation both smooths climate records, by damping fast climate variations, and creates noise when measurements are made on samples containing small numbers of individual proxy carriers, such as foraminifera. Bioturbation also influences radiocarbon-based age-depth models, as sample ages may not represent the true ages of the sediment layers from which they were picked. While these effects were first described several decades ago, the advent of ultra-small-sample 14C dating now allows samples containing very small numbers of foraminifera to be measured, thus enabling us to directly measure the age-heterogeneity of sediment for the first time. Here, we use radiocarbon dates measured on replicated samples of 3-30 foraminifera to estimate age-heterogeneity for five marine sediment cores with sedimentation rates ranging from 2-30 cm / kyr. From their age-heterogeneities and sedimentation rates we infer mixing depths of 10-20 cm for our core sites. Our results show that when accounting for age-heterogeneity, the true error of radiocarbon dating can be several times larger than the reported measurement. We present estimates of this uncertainty as a function of sedimentation rate and the number of individuals per radiocarbon date. A better understanding of this uncertainty will help us to optimise radiocarbon measurements, construct age models with appropriate uncertainties and better interpret marine paleo records

De Nederlandse landbouwexport 2018 in breder perspectief

This report describes the trade developments in the agricultural sector in the Netherlands in 2018. In this joint publication by Wageningen Economic Research and Statistics Netherlands (CBS), which was commissioned by the Ministry of Agriculture, Nature and Food Quality (LNV), the initial trade results are announced and interpreted. Additionally, an overview of patents in the agricultural processing industry is given as well as an inventory of the current situation of technological innovations in the agricultural industry. The report also describes the number of agricultural subsidiaries abroad and contains information regarding foreign students who have graduated. Finally, a reflection on trade and circularity has been included

The state of the Martian climate

60°N was +2.0°C, relative to the 1981–2010 average value (Fig. 5.1). This marks a new high for the record. The average annual surface air temperature (SAT) anomaly for 2016 for land stations north of starting in 1900, and is a significant increase over the previous highest value of +1.2°C, which was observed in 2007, 2011, and 2015. Average global annual temperatures also showed record values in 2015 and 2016. Currently, the Arctic is warming at more than twice the rate of lower latitudes

'Tipping the Balance': Karl Friedrich Meyer, Latent Infections, and the Birth of Modern Ideas of Disease Ecology

The Swiss-born medical researcher Karl Friedrich Meyer (1884–1974) is best known as a ‘microbe hunter’ who pioneered investigations into diseases at the intersection of animal and human health in California in the 1920s and 1930s. In particular, historians have singled out Meyer’s 1931 Ludwig Hektoen Lecture in which he described the animal kingdom as a ‘reservoir of disease’ as a forerunner of ‘one medicine’ approaches to emerging zoonoses. In so doing, however, historians risk overlooking Meyer’s other intellectual contributions. Developed in a series of papers from the mid-1930s onwards, these were ordered around the concept of latent infections and sought to link microbial behavior to broader bio-ecological, environmental, and social factors that impact hostpathogen interactions. In this respect Meyer—like the comparative pathologist Theobald Smith and the immunologist Frank Macfarlane Burnet—can be seen as a pioneer of modern ideas of disease ecology. However, while Burnet’s and Smith’s contributions to this scientific field have been widely acknowledged, Meyer’s have been largely ignored. Drawing on Meyer’s published writings and private correspondence, this paper aims to correct that lacuna while contributing to a reorientation of the historiography of bacteriological epidemiology. In particular I trace Meyer’s intellectual exchanges with Smith, Burnet and the animal ecologist Charles Elton, over brucellosis, psittacosis and plague—exchanges that not only showed how environmental and ecological conditions could ‘tip the balance’ in favor of parasites but which transformed Meyer thinking about resistance to infection and disease

Marine Noise Pollution - Increasing Recognition But Need for More Practical Action

Over the last two decades, marine noise pollution has become increasingly recognized as an issue of major significance. The issue has become a primary focus of marine mammal research, but is also of concern to the public and policy makers. The result has been efforts involving a variety of disciplines, and relevant legislation and associated guidance are now in place in many parts of the world. Most current mitigation efforts are directed at reducing the risk of injury from exposure to intense noise, although the effectiveness of such mitigation measures in terms of risk reduction has rarely been quantified. Longer-term chronic impacts of noise including disturbance or masking of sounds critical for feeding and reproduction have received substantially less attention in management. New technologies are being developed for a number of activities which can substantially reduce noise inputs into the marine environment. As with other forms of pollution, reducing input at source is likely to be the most effective way of reducing impacts. We recommend as a priority the implementation of noise quieting technologies and the spatial and temporal exclusion of noise to minimize contact with marine life

Why Are Outcomes Different for Registry Patients Enrolled Prospectively and Retrospectively? Insights from the Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF).

Background: Retrospective and prospective observational studies are designed to reflect real-world evidence on clinical practice, but can yield conflicting results. The GARFIELD-AF Registry includes both methods of enrolment and allows analysis of differences in patient characteristics and outcomes that may result. Methods and Results: Patients with atrial fibrillation (AF) and ≥1 risk factor for stroke at diagnosis of AF were recruited either retrospectively (n = 5069) or prospectively (n = 5501) from 19 countries and then followed prospectively. The retrospectively enrolled cohort comprised patients with established AF (for a least 6, and up to 24 months before enrolment), who were identified retrospectively (and baseline and partial follow-up data were collected from the emedical records) and then followed prospectively between 0-18 months (such that the total time of follow-up was 24 months; data collection Dec-2009 and Oct-2010). In the prospectively enrolled cohort, patients with newly diagnosed AF (≤6 weeks after diagnosis) were recruited between Mar-2010 and Oct-2011 and were followed for 24 months after enrolment. Differences between the cohorts were observed in clinical characteristics, including type of AF, stroke prevention strategies, and event rates. More patients in the retrospectively identified cohort received vitamin K antagonists (62.1% vs. 53.2%) and fewer received non-vitamin K oral anticoagulants (1.8% vs . 4.2%). All-cause mortality rates per 100 person-years during the prospective follow-up (starting the first study visit up to 1 year) were significantly lower in the retrospective than prospectively identified cohort (3.04 [95% CI 2.51 to 3.67] vs . 4.05 [95% CI 3.53 to 4.63]; p = 0.016). Conclusions: Interpretations of data from registries that aim to evaluate the characteristics and outcomes of patients with AF must take account of differences in registry design and the impact of recall bias and survivorship bias that is incurred with retrospective enrolment. Clinical Trial Registration: - URL: http://www.clinicaltrials.gov . Unique identifier for GARFIELD-AF (NCT01090362)

1-meting barometer duurzame landbouw Zuid-Holland : trends en ontwikkelingen in de akkerbouw en melkveehouderij

De Barometer gaat over de duurzaamheidsprestaties van de grondgebonden landbouw in Zuid-Holland en omvat een groot aantal indicatoren op people-, planet- en profit-thema’s. Het betreft een update van de eerste Barometer met recentere data. Het gemiddelde akkerbouwbedrijf in Zuid-Holland is in 2017 beter gaan presteren op het gebied van fosfaatbenutting en milieubelastingspunten per hectare ten opzichte van het meerjaarsgemiddelde (2010-2015). Op het gebied van stikstofoverschot en met name inkomen uit bedrijf zijn bedrijven minder duurzaam geworden. Het gemiddelde melkveebedrijf is over dezelfde periode beter gaan presteren op het gebied van inkomen uit bedrijf per onbetaalde arbeidsjaareenheid, stikstofoverschot en fosfaatoverschot per hectare en energie-efficiëntie. Daar stond tegenover dat de melkproductie per hectare toenam en het aandeel bedrijven dat huisverkoop toepaste afnam

Prescribing anti-epileptic drugs for people with epilepsy and intellectual disability

This report addresses the extremely important area of epilepsy in the field of intellectual disability (ID), also known as learning disability. Epilepsy and ID are two conditions that carry stigma and can lead to social isolation. An individual who experiences both these problems faces huge challenges. This report aims to provide epileptologists, psychiatrists, doctors and clinicians working with people with ID and epilepsy an overview of good practice prescribing. Its focus is on using current evidence and applying it to support practical prescribing for people with ID. The document is not a substitute for recognised prescribing guides such as the British National Formulary (BNF). It is not a complete or comprehensive overview of epilepsy management or of epilepsy service provision. The contents of this report need to be considered as guidance, especially where most practitioners struggle when the evidence does not inform the complex clinical challenges. The report is a consensus statement on the application of current evidence used in the general population to people with ID and should be used for the purpose of guiding holistic decision-making in prescribing AEDs. It is important that clinicians keep themselves up to date using the latest information on the subject as part of their continuing professional development, as the subject area covered by this report changes rapidly